Stryker, Johnson & Johnson and Zimmer Biomet posted their fourth-quarter and full-year financial results for 2025, along with data on their spine orthopedic sales.
Here is how they compare:
2025 sales: $25.1 billion (+11.2%)
2025 Orthopedics: $9.5 billion (+4.3%)
2025 Hips: $1.9 billion (+9.5%)
2025 Knees: $2.7 billion (+8.5%)
2025 Spine: $185 million
Q4 sales: $7.2 billion (+11.4%)
2025 sales: $8.2 billion (+7.2%)
2025 Hips: $2 million (+4.7%)
2025 Knees: $3.2 billion (+4.7%)
2025 Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $2.1 billion (+15.2%)
Q4 sales: $2.24 billion
2025 Medtech sales: $94.2 billion (+6%)
2025 Orthopedic: $9.2 billion (+1.1%)
2025 Spine, sports and other: $2.8 billion (-2.5%)
2025 Hips: $1.67 billion (+2.1%)
2025 Knees: $1.58 billion (+2.7%)
Q4 sales: $24.6 billion (+9.1%)
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
